Seaside Therapeutics' Series C Round

Seaside Therapeutics raised a round of funding on September 21, 2009.

Seaside Therapeutics is creating new drug treatments to correct or improve the course of Fragile X Syndrome, autism and other disorders of brain development.…

Articles about Seaside Therapeutics' Series C Round: